Intermittent Oral Administration vs. Semi-continuous Intra-oral Administration of Levodopa/Carbidopa in Fluctuating Parkinsonian Patients

NCT02763137 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: Standard LD/CD
DRUG: Semi continuous intra-oral administration of LD/CD

Sponsor

IRCCS San Raffaele Roma

Collaborators

[object Object]